CZI
(2R)-8-BENZYL-2-HYDROPEROXY-6-(4-HYDROXYPHENYL)-2-(4-IODOBENZYL)-7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN-3(2H)-ONE
| Created: | 2003-07-07 |
| Last modified: | 2021-03-01 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 56 |
| Chiral Atom Count | 2 |
| Bond Count | 60 |
| Aromatic Bond Count | 18 |
Chemical Component Summary | |
|---|---|
| Name | (2R)-8-BENZYL-2-HYDROPEROXY-6-(4-HYDROXYPHENYL)-2-(4-IODOBENZYL)-7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN-3(2H)-ONE |
| Synonyms | I-COELENETERAZINE |
| Systematic Name (OpenEye OEToolkits) | (2S)-2-hydroperoxy-6-(4-hydroxyphenyl)-2-[(4-iodophenyl)methyl]-8-(phenylmethyl)-7,8-dihydroimidazo[3,2-a]pyrazin-3-one |
| Formula | C26 H22 I N3 O4 |
| Molecular Weight | 567.375 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 10.04 | Ic1ccc(cc1)CC5(OO)N=C2N(C=C(NC2Cc3ccccc3)c4ccc(O)cc4)C5=O |
| SMILES | CACTVS | 3.341 | OO[C]1(Cc2ccc(I)cc2)N=C3[CH](Cc4ccccc4)NC(=CN3C1=O)c5ccc(O)cc5 |
| SMILES | OpenEye OEToolkits | 1.5.0 | c1ccc(cc1)CC2C3=NC(C(=O)N3C=C(N2)c4ccc(cc4)O)(Cc5ccc(cc5)I)OO |
| Canonical SMILES | CACTVS | 3.341 | OO[C@]1(Cc2ccc(I)cc2)N=C3[C@@H](Cc4ccccc4)NC(=CN3C1=O)c5ccc(O)cc5 |
| Canonical SMILES | OpenEye OEToolkits | 1.5.0 | c1ccc(cc1)CC2C3=N[C@@](C(=O)N3C=C(N2)c4ccc(cc4)O)(Cc5ccc(cc5)I)OO |
| InChI | InChI | 1.03 | InChI=1S/C26H22IN3O4/c27-20-10-6-18(7-11-20)15-26(34-33)25(32)30-16-23(19-8-12-21(31)13-9-19)28-22(24(30)29-26)14-17-4-2-1-3-5-17/h1-13,16,22,28,31,33H,14-15H2/t22-,26+/m1/s1 |
| InChIKey | InChI | 1.03 | VKJBKKSOPAEBAT-GJZUVCINSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB04146 |
|---|---|
| Name | I-Coeleneterazine |
| Groups | experimental |
| Synonyms | I-Coeleneterazine |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 49866867 |














